CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. Its Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals. This segment operates retail specialty pharmacy stores; and specialty mail-order, mail-order dispensing, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The company's Retail/LTC segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products; and provides health care services through its MinuteClinic walk-in medical clinics. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. As of December 31, 2021, it operated approximately 9,900 retail locations and 1,200 MinuteClinic locations, as well as online retail pharmacy websites, LTC pharmacies, and onsite pharmacies. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.

Finucane Anne A.

SANSONE GUY P

CVS Health stock surged 6.09% to a new 52-week high after reporting strong Q1 earnings of $2.57 per share (beating $2.20 estimates) and raising 2026 guidance. The company's medical benefit ratio improved to 84.6% from 87.3%, driven by better Government business performance. CVS also announced plans to expand biosimilar adoption in its formularies starting July 1, 2026, prioritizing lower-cost alternatives over branded drugs.

CVS Health's Lower Medical Cost Ratio Lift Profit, Outlook

The S&P 500 climbed to a record high on Tuesday, rising 0.81% to 7,259.22, driven by easing oil prices, strong corporate earnings (84% beat expectations), and positive geopolitical sentiment. Polymarket shows 88% odds of an up open on Wednesday. S&P 500 futures were higher early Wednesday, with semiconductor stocks and AI-linked trades providing momentum.

Will S&P 500 Open Up Or Down On Wednesday?

Making confident traders since 2009! Join the 'Art Of Trading' community today!

https://t.co/Dp8OvaAgdi

Blog: https://t.co/sCi8fDzBJB

Traderstewie

Swing trader,  over 15 years experience. Exclusive trade Ideas + set-ups shared for $10/month. Click "Subscribe" in my profile to join. NO investment advice

Jack

Get Trading Activities on X and Personalized AI Stock Analysis. Not investment advice. Sign up for free at https://t.co/Szbuf7KmLT

Fintwit.ai

Research-driven thematic investor & swing trader. Not financial advice

Subscribe: https://t.co/tRfuPuBAXn

Venu

All stocks and economy. All the time. Except when I mix in references to sports and pop culture. Senior markets analysis writer @barronsonline. Ex-@CNNBusiness.

CVS Health Corp (CVS) Stock Price, Analysis & Trade Signals